Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Jaffe

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2023
Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry StudyCatherine Mezzacappa, Raiza Rossi, Ariel Jaffe, et al.
Frontiers in Applied Mathematics and Statistics|September 10, 2021
The Spectral Underpinning of word2vecAriel Jaffe, Yuval Kluger, Ofir Lindenbaum, et al.
SIAM Journal on Mathematics of Data Science|June 14, 2021
Spectral neighbor joining for reconstruction of latent tree ModelsAriel Jaffe, Noah Amsel, Yariv Aizenbud, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2025
DiCoLo: Integration-free and cluster-free detection of localized differential gene co-expression in single-cell dataRuiqi Li, Junchen Yang, Pei-Chun Su, et al.
Hepatology (Baltimore, Md.)|March 3, 2022
Diabetes medications and risk of HCCMaria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, et al.
Hepatology (Baltimore, Md.)|February 1, 2023
Reply: Novel antidiabetic drugs and the risk for HCC. What else to expect from these "wonderful" drug classes?Maria C Plaz Torres, Ariel Jaffe, Rachel Perry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCCAriel Jaffe, Tamar H Taddei, Edoardo G Giannini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2022
Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbookAriel Jaffe, Tamar H Taddei, Edoardo G Giannini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 14, 2022
Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysisStefano Kayali, Andrea Pasta, Maria Corina Plaz Torres, et al.
Clinical Imaging|March 6, 2025
Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACEVictor Kasolowsky, Moritz Gross, David C Madoff, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2023
Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry StudyCatherine Mezzacappa, Raiza Rossi, Ariel Jaffe, et al.
Frontiers in Applied Mathematics and Statistics|September 10, 2021
The Spectral Underpinning of word2vecAriel Jaffe, Yuval Kluger, Ofir Lindenbaum, et al.
SIAM Journal on Mathematics of Data Science|June 14, 2021
Spectral neighbor joining for reconstruction of latent tree ModelsAriel Jaffe, Noah Amsel, Yariv Aizenbud, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2025
DiCoLo: Integration-free and cluster-free detection of localized differential gene co-expression in single-cell dataRuiqi Li, Junchen Yang, Pei-Chun Su, et al.
Hepatology (Baltimore, Md.)|March 3, 2022
Diabetes medications and risk of HCCMaria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, et al.
Hepatology (Baltimore, Md.)|February 1, 2023
Reply: Novel antidiabetic drugs and the risk for HCC. What else to expect from these "wonderful" drug classes?Maria C Plaz Torres, Ariel Jaffe, Rachel Perry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCCAriel Jaffe, Tamar H Taddei, Edoardo G Giannini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2022
Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbookAriel Jaffe, Tamar H Taddei, Edoardo G Giannini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 14, 2022
Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysisStefano Kayali, Andrea Pasta, Maria Corina Plaz Torres, et al.
Clinical Imaging|March 6, 2025
Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACEVictor Kasolowsky, Moritz Gross, David C Madoff, et al.
Pageof 4